Facebook
Instagram
Pinterest
Reddit
Tumblr
X
Youtube
Home
About
News
Events
Shop
Directory
Contact Us
Search
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
PsyNews.com
Home
About
News
Events
Shop
Directory
Contact Us
Home
Featured
Page 151
Featured
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Pα+ Psychedelic Bulletin #225: Q1 Lobbying Update; Individual vs. Group MDMA Therapy Study Launches; Australia Loosens Psychedelics Access Regulations; VA Launches “New” MDMA Trial
Three Brain Injuries, One Iboga Protocol, and What It Tells Us
The War on Drugs Was Never About Drugs. Psychedelic Healing Must Reckon With That.
A Dispatch from APA’s Annual Meeting: Psychedelics Return at an Awkward Moment for American Psychiatry
Momentum Amidst Tumult: The FDA Reshuffle, Approval Timelines, and the Compass-Usona Race
Empyrean Neuroscience Launches with $22M Series A and Genetic Engineering Platform...
PT365 – Dr. Jennifer Montjoy – KAP: Self-Agency Through Intention, Titration,...
Small Pharma Reports Fiscal Second Quarter 2023 Highlights
Revive Therapeutics Announces Finalization of Amended Phase 3 COVID-19 Study Protocol...
Algernon Pharmaceuticals Announces Dr. Rick Strassman author of “DMT: The Spirit...
Acid for Anxiety: Fast and Lasting Anxiolytic Effects of LSD
PT364 – Jamie Wheal – Burning Man, Psychedelic Maturity, and Radical...
atai Life Sciences Announces Positive Initial Results for Phase 1 Trial...
FILAMENT HEALTH TO HOST VIRTUAL INVESTOR UPDATE
Reunion Neuroscience CEO to Participate on Panel at 2022 Horizons Perspectives...
Load more
